Medtronic plc Stock

There are compelling reasons for some investors to consider investing in Medtronic (NYSE: MDT), depending on their goals and risk tolerance. It is a well-established healthcare leader that generates

Medtronic (NYSE: MDT), a medical device specialist, has lagged the market over the past five years. The company has experienced slow revenue growth, significant competition in some of its niches --

It's been a good year for Medtronic (NYSE: MDT), a medical device specialist. Despite the threat of tariffs, the healthcare leader has generally delivered strong financial results and has

Dividend Kings are the royalty of dividend stocks. These companies have increased their payments every single year for half a century. It's an elite group, with only 56 companies currently meeting

Dividend-paying stocks are great for the passive income they provide to those who choose to take their payouts in cash, and also for the opportunity to boost the long-term returns of those who

Identifying good companies isn't always easy, but there are shortcuts you can take.

One of my favorite is focusing on companies that have a long history of annual dividend increases behind them

Intuitive Surgical (NASDAQ: ISRG) has dominated the market for robotic-assisted surgery (RAS) devices for the better part of the last 20 years, with little competition to speak of in many of the

Some investors fear that President Donald Trump's aggressive tariffs will lead to economic troubles such as inflation. While things may or may not turn out that way, it's still a good idea to

Medtronic (NYSE: MDT) is out of favor today, noting it has a historically high dividend yield of around 3%. The company is working on improving its business performance, however, and stronger

The list of Dividend Kings -- the very few U.S.-traded stocks that have enacted dividend raises at least once annually for a minimum of 50 years in a row -- is extremely short. That's why it's quite

Ken Griffin is the founder and CEO of Citadel, a hedge fund established in 1990, whose long-term performance has been excellent. Citadel's track record suggests that Griffin knows a thing or two

Dividend stocks that offer high yields can be gold mines for your portfolio as they can generate loads of recurring income for you for years. Whether you want to use the money to reinvest in those

One of the highest honors among dividend stocks is to be a Dividend Aristocrat®, which requires 25 consecutive years or more in annual increases. The title Dividend Aristocrat is such a big deal

Dividend investing can be tricky, since income-focused investors want to find high yields while also avoiding stocks that end up cutting their quarterly payouts. There's a balance that has to be

Dividend stocks aren't all created equal. Some decrease their payouts, or suspend them altogether, when they face headwinds. Others have much stronger businesses and continue to raise their

I happily own stock in Medtronic (NYSE: MDT), one of the largest medical device makers in the world. Of late, the company is struggling through a rough patch that has Wall Street worried about the

The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 billion. One reason behind this rapid growth is that these robot systems

A clutch of post-earnings price target increases by analysts helped raise Medtronic's (NYSE: MDT) stock at a healthy rate on Wednesday. The sturdy medical device specialist's shares rose by almost

The average healthcare stock has a yield of just 1.8%, which isn't much to write home about today. You can do much better than that with Medtronic (NYSE: MDT), currently yielding 3%, or if you're

Medtronic (NYSE: MDT) stock had declined 3.6% through 2:45 p.m. ET Tuesday despite beating forecasts for fiscal 2026 first-quarter earnings this morning.

Heading into the report, analysts predicted

Medtronic (NYSE:MDT), a global medical technology leader specializing in cardiovascular, neuroscience, and surgical devices, reported Q1 FY2026 earnings on August 19, 2025. The most notable news

Medtronic (NYSE: MDT) isn't getting much love on Wall Street today. The stock has fallen around 33% since hitting a peak in mid-2021. That's a huge decline, but it may be overdone. Sure, there are